Filing Details
- Accession Number:
- 0001209191-17-031602
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-11 18:15:54
- Reporting Period:
- 2017-05-09
- Filing Date:
- 2017-05-11
- Accepted Time:
- 2017-05-11 18:15:54
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1625101 | Pulse Biosciences Inc. | PLSE | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1055919 | W Robert Duggan | 611 S. Fort Harrison Ave., Suite 306 Clearwater FL 33756 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-05-09 | 1,300 | $19.43 | 2,984,227 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-09 | 5,000 | $20.07 | 2,989,227 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-09 | 19,489 | $21.47 | 3,008,716 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-11 | 10,100 | $20.55 | 3,018,816 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2017-05-11 | 7,500 | $21.52 | 3,026,316 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 35,000 | Indirect | See footnote |
Footnotes
- This is the weighted average purchase price of the shares, which ranged from $18.98 to $19.95 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
- This is the weighted average purchase price of the shares, which ranged from $21.153 to $21.75 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
- This is the weighted average purchase price of the shares, which ranged from $20.451 to $20.60 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
- This is the weighted average purchase price of the shares, which ranged from $21.47 to $21.737 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
- Shares are held by Genius Accelerated LLC, of which the Reporting Person is the sole member and beneficiary.